Parsa et al. found that glioma cells lines (SF126, SF210, U87, U251, and U373) with genetic deletions or mutations in phosphatase and tensin homologue (PTEN) had higher PD-L1 protein levels than cells wild-type for PTEN18. The gene discussed is PTEN; the disease is central nervous system cancer.